Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.24m15569 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Kaoruhiko Kubo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Haloperidol, Delirium, Hydroxyzine, Antipsychotic Agents.
Themen: Delir
Abstract (Originalsprache)
Objective
Although antipsychotics are used commonly for delirium, they increase the risk of mortality in elderly patients and those with dementia. As hydroxyzine has sedative and anxiolytic effects, it can be used in the treatment of delirium. We performed a retrospective study to compare the effects of intravenous hydroxyzine and haloperidol monotherapy on delirium.
Methods
Patients who admitted to a university hospital from April 1, 2017, to September 30, 2022, and received either hydroxyzine or haloperidol intravenously as monotherapy for the treatment of delirium were included. The time to and rate of delirium improvement were compared. Improvement of delirium was defined as negative on the Confusion Assessment Method (CAM) or Confusion Assessment Method for the ICU (CAM-ICU) for 3 consecutive days.
Results
Among 5,555 patients who developed delirium, 71 (1.3%) and 82 (1.5%) received intravenous hydroxyzine and haloperidol monotherapy, respectively. The time to delirium improvement was 7.0 days (95% CI, 5.7-8.3 days) for hydroxyzine and 8.2 days (95% CI, 7.6-8.8 days) for haloperidol, with no significant difference between the two groups (P = .059). On the other hand, the rate of delirium improvement was 23.9% for hydroxyzine and 8.5% for haloperidol, with a significant difference in favor of the hydroxyzine group (P = .009).
Conclusions
We first showed that intravenous hydroxyzine monotherapy was not inferior for the time to delirium improvement and superior for the rate of delirium improvement to intravenous haloperidol monotherapy. Considering that hydroxyzine is relatively safe with few side effects, it can be a viable option for delirium as an alternative to antipsychotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
- Department of Nursing, Keio University Hospital, Tokyo, Japa.
- Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
- Corresponding Author: Hiroyoshi Takeuchi, MD, PhD, Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan (hirotak@dk9.so-net.ne.jp).
Zitieren
APA
Kubo, K., Takehara, M., Hirata, M., Huh, S., Kawano, S., Uchida, H., & Takeuchi, H. (2025). Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.24m15569
Vancouver
Kubo K, Takehara M, Hirata M, Huh S, Kawano S, Uchida H, et al. Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.24m15569
BibTeX
@article{Kubo2025,
author = {Kubo, Kaoruhiko and Takehara, Moe and Hirata, Mayuko and Huh, Sunjun and Kawano, Sayoko and Uchida, Hiroyuki and Takeuchi, Hiroyoshi},
title = {Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.24m15569}
}
EUVIMED